Disease Awareness

Today we’re pleased to say that our widely-used BinaxNOW rapid test, the size of a credit card and requiring no instrumentation, has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for use at home with a prescription through a virtually guided online service.

The new CalOSHA regulations to protect California workers from getting COVID-19 in the workplace have arrived. The timing coincides with increasing case rates and more statewide lockdowns. Here is a brief summary of the emergency standards.

Less than a year into the COVID-19 pandemic, pharmaceutical companies are beginning to roll out the first vaccines. Ecolab has provided vital support at every stage of the process.

As this year winds down, it’s hard not to notice the weariness that’s come from shifting almost every area of our lives — from work to school, workouts to happy hours — to some form of video call.

As the COVID-19 pandemic deepened, leading U.S. engineering and construction firms joined forces in May, leveraging their deep safety expertise and best practices in a campaign to ensure the well-being of crews and office teams facing the outbreak

There’s a need to forge alliances and working groups to mitigate the COVID-19 pandemic’s impact.

Today’s events not only make us confront these issues, but also push us to re-evaluate and co-innovate. Here are 3 imperatives to find solutions for a more equitable, safer and resilient world.

With more than 40,000 essential workers at JFK, the new site will bolster outreach to this critical frontline group while also allowing those who must travel the chance to test before & after a flight and receive results within 48 hours on average.

Ecolab Inc. is the first to receive EPA product approval for disinfection of biofilms in wastewater drains for its Virasept™ product – an important part of a comprehensive environmental hygiene program designed to help effectively combat bacterial growth in hospitals.

Prostate cancer is the most frequently diagnosed cancer amongst Brazilian men, and is the second leading cause of death among male cancer patients, according to the Brazilian National Cancer Institute (INCA).